Takamasa Oono

Tetsuhide Ito2
Hisato Igarashi2
Yusuke Niina2
Nao Fujimori2
2Tetsuhide Ito
2Hisato Igarashi
2Yusuke Niina
Learn More
Multiple endocrine neoplasia type 1 (MEN1) is an inherited autosomal dominant disease presenting with pancreatic neuroendocrine tumors (pNETs), parathyroid tumors, or pituitary tumors. Using the PubMed database, we reviewed the literature on information regarding the proper diagnosis and treatment of MEN1-associated pNET. Many cases of MEN1-associated pNET(More)
  • Hisato Igarashi, Tetsuhide Ito, Terumasa Hisano, Nao Fujimori, Yusuke Niina, Mikihiko Yasuda +6 others
  • 2011
BACKGROUND/OBJECTIVES Gemcitabine (GEM) is a gold-standard chemotherapy agent for advanced pancreatic cancer. Because of the malignant character of the disease, nearly all patients show disease progression despite treatment with GEM-based chemotherapy; therefore, second-line chemotherapy may be beneficial for these patients. We report a retrospective(More)
  • 1